ESTRO, the European SocieTy for Radiotherapy & Oncology,supports all the Radiation Oncology professionals in their daily practice: Radiation Oncologists, Medical Physicists, Radiobiologists and RTTs (Radiation TherapisTs) and the wider oncology community. ESTRO’s mission is to promote innovation, research, and dissemination of science through its congresses, special meetings, educational courses and publications. From 5-9 May 2017 ESTRO 36 will take place in Vienna, Austria.
Two REQUITE posters will be presented:
- REQUITE: Radiation Induced Lymphocyte Apoptosis assay as a predictor for radiotherapy side effects, C. Talbot, et al. To read the abstract click here.
- Optimal design and patient selection for interventional trials using radiogenomic biomarkers, D. De Ruysscher, et al. To read the abstract click here.